Literature DB >> 17238178

Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer.

Reshma Jagsi1, Kent A Griffith, Todd Koelling, Rachel Roberts, Lori J Pierce.   

Abstract

BACKGROUND: Radiation therapy (RT), a critical component of breast-conserving therapy for breast cancer, has been associated with coronary artery disease (CAD) in numerous older studies, but the risk may be lower with modern techniques.
METHODS: Observed rates of cardiac events in 828 patients treated with breast-conserving surgery and RT at the University of Michigan were compared with expected rates. Relations between potential risk factors and actuarial rates of first CAD event were analyzed.
RESULTS: Observed risks of cardiac events were lower than expected. The standardized incidence ratio (SIR) of myocardial infarction (MI) was 0.44 (95% confidence interval [CI]: 0.21-0.70). The SIR of MI or CAD requiring intervention was 0.50 (95% CI: 0.27-0.68). With a median follow-up of 6.8 years, 12 (1.4%) patients had at least 1 MI on follow-up and 20 (2.4%) had at least 1 MI or CAD requiring intervention. Median age at first cardiac event was 75.9 years (range, 43.1-91.5). Median interval from RT to occurrence of the first cardiac event was 3.7 years (range, 13 days to 15.4 years). The 10-year cumulative incidence of MI was 1.2% and cumulative incidence of MI or CAD requiring intervention was 2.7%. On multivariate analysis, age, diabetes mellitus, active smoking, and laterality of RT were significant predictors of MI. Age and active smoking were significant predictors of MI or CAD requiring intervention.
CONCLUSIONS: Patients in this series had lower risk of ischemic cardiac events than expected. Although small in absolute magnitude, patients radiated to the left side did have a statistically significant increased risk of MI. These findings support further investigation of techniques to minimize the long-term cardiac risks faced by breast cancer patients.

Entities:  

Mesh:

Year:  2007        PMID: 17238178     DOI: 10.1002/cncr.22452

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  28 in total

1.  Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer.

Authors:  Mary Feng; Jean M Moran; Todd Koelling; Aamer Chughtai; June L Chan; Laura Freedman; James A Hayman; Reshma Jagsi; Shruti Jolly; Janice Larouere; Julie Soriano; Robin Marsh; Lori J Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-24       Impact factor: 7.038

2.  Concomitant adjuvant chemo-radiation therapy with anthracycline-based regimens in breast cancer: a single centre experience.

Authors:  L Livi; I Meattini; V Scotti; C Saieva; G Simontacchi; L Marrazzo; C Franzese; S Cassani; F Paiar; V Di Cataldo; J Nori; L Jose Sanchez; S Bianchi; L Cataliotti; G Biti
Journal:  Radiol Med       Date:  2011-03-07       Impact factor: 3.469

3.  Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.

Authors:  Alice Y Ho; Ase Ballangrud; Guang Li; Gaorav P Gupta; Beryl McCormick; Richard Gewanter; Daphna Gelblum; Melissa Zinovoy; Boris Mueller; Borys Mychalczak; Pinaki Dutta; Karen Borofsky; Preeti Parhar; Marsha Reyngold; Lior Z Braunstein; Mohit Chawla; Kate Krause; Natasha Freeman; Chun Ting Siu; Zachary Cost; Brittany B Arnold; Zhigang Zhang; Simon N Powell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-30       Impact factor: 7.038

4.  Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer.

Authors:  Terry S Field; Jaclyn L F Bosco; Marianne N Prout; Heather T Gold; Sarah Cutrona; Pamala A Pawloski; Marianne Ulcickas Yood; Virginia P Quinn; Soe Soe Thwin; Rebecca A Silliman
Journal:  J Am Coll Surg       Date:  2011-10-19       Impact factor: 6.113

5.  Is there a dose-response relationship for heart disease with low-dose radiation therapy?

Authors:  Eugene Chung; James R Corbett; Jean M Moran; Kent A Griffith; Robin B Marsh; Mary Feng; Reshma Jagsi; Marc L Kessler; Edward C Ficaro; Lori J Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-27       Impact factor: 7.038

6.  Effect of accurate heart delineation on cardiac dose during the CONVERT trial.

Authors:  Nicki Groom; Elena Wilson; Corinne Faivre-Finn
Journal:  Br J Radiol       Date:  2017-03-31       Impact factor: 3.039

7.  Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials.

Authors:  Erica N Peters; Essie Torres; Benjamin A Toll; K Michael Cummings; Ellen R Gritz; Andrew Hyland; Roy S Herbst; James R Marshall; Graham W Warren
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

8.  Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer.

Authors:  Reshma Jagsi; Jean Moran; Robin Marsh; Kathryn Masi; Kent A Griffith; Lori J Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-09-09       Impact factor: 7.038

9.  Intima-media thickness, myocardial perfusion and laboratory risk factors of atherosclerosis in patients with breast cancer treated with anthracycline-based chemotherapy.

Authors:  Hana Kalábová; Bohuslav Melichar; Leoš Ungermann; Jiří Doležal; Lenka Krčmová; Markéta Kašparová; Jiří Plíšek; Radomír Hyšpler; Miroslav Pecka; Dagmar Solichová
Journal:  Med Oncol       Date:  2010-06-22       Impact factor: 3.064

10.  Comorbidities and cardiovascular disease risk in older breast cancer survivors.

Authors:  Reina Haque; Marianne Prout; Ann M Geiger; Aruna Kamineni; Soe Soe Thwin; Chantal Avila; Rebecca A Silliman; Virginia Quinn; Marianne Ulcickas Yood
Journal:  Am J Manag Care       Date:  2014       Impact factor: 2.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.